Open AccessS0643 Composite and Individual Measures of Efficacy and Safety of Upadacitinib Treatment for Crohn's Disease: 12-Month Results From the Ongoing Phase 2 CELEST Open-Label Extension Study
Author(s) -
Geert R. D’Haens,
Julián Panés,
Édouard Louis,
Qian Zhou,
Jianzhong Liu,
Ana P. Lacerda,
Edward V. Loftus
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704620.03018.6c
Subject(s) - medicine , gastroenterology , inflammatory bowel disease , clinical endpoint , abdominal pain , clinical trial , open label , surgery , disease